Request Deal Involvement

Frazier Life Sciences led a $187m Series A round in Callio Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Latham & Watkins

legal advisors

Latham & Watkins

Baker McKenzie

legal advisors

Baker McKenzie

or

Principals

OMEGA FUNDS

bidder

OMEGA FUNDS

CALLIO THERAPEUTICS

target

CALLIO THERAPEUTICS

FRAZIER LIFE SCIENCES

bidder

FRAZIER LIFE SCIENCES

JEITO CAPITAL

bidder

JEITO CAPITAL

PLATANUS

bidder

PLATANUS

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

CLAVYSTBIO

bidder

CLAVYSTBIO

NORWEST EQUITY PARTNERS

bidder

NORWEST EQUITY PARTNERS

SEEDS CAPITAL

bidder

SEEDS CAPITAL

PUREOS BIOVENTURES

bidder

PUREOS BIOVENTURES

EDBI

bidder

EDBI

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite